News

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.

The study, published Sept. 3 in JAMA Network Open, found that older adults living in flood-hit areas in New Jersey faced a 5% higher risk of heart disease for up to five years after Sandy’s landfall. This is one of the first studies to rigorously quantify long...

The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in the U.S. to use a genetically engineered pig liver to support patients with severe liver failure who don’t qualify for a transplant, according to an American Journal of Transplantation (AJT) report published in August.

“We’ve waited over two decades since the last trial of a bioartificial liver device,” says Dr. Robert Brown,  Chief of the Division of Gastroenterology and Hepatology and a leading...

A new study co-authored by Dr. Felice Schnoll-Sussman, Director of the Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian and Weill Cornell Medicine, shows promising results for combined colon and endometrial screening for patients with Lynch syndrome, a genetic condition in which individuals face up to a 60% lifetime risk of developing endometrial and gastrointestinal cancers.

This patient-centric program evolved from the desire to improve the quality of life and...

The Fund for the Future award supports selected junior faculty during a crucial period in their career development - the completion of their research training into the early years of their first faculty position at Weill Cornell Medicine. Backed by the generosity of donors to the Weill Department of Medicine (WDOM) and Iris Cantor Center for Women’s Health, funding is based upon academic progress and a competitive training award (such as an NIH K) application timeline within 18 months of...